1 |
Gelman AE, LaRosa DF, Zhang J, Walsh PT, Choi Y, Sunyer JO, Turka LA: The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 25;783-793, 2006
DOI
ScienceOn
|
2 |
Cottalorda A, Verschelde C, Mar ais A, Tomkowiak M, Musette P, Uematsu S, Akira S, Marvel J, Bonnefoy-Berard N: TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation 36;1684-1693,2006
DOI
ScienceOn
|
3 |
Asprodites N, Zheng L, Geng D, Velasco-Gonzalez C, Sanchez-Perez L, Davila E: Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J 22;3628-3637, 2008
DOI
ScienceOn
|
4 |
Wong P, Lara-Tejero M, Ploss A, Leiner I, Pamer EG: Rapid development of T cell memory. J Immunol 172;7239-7245, 2004
DOI
PUBMED
|
5 |
Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R, Luppa PB, Ebel F, Busch DH, Bauer S, Wagner H, Kirschning CJ: Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113:1473-1481, 2004
DOI
PUBMED
|
6 |
Gelman AE, Zhang J, Choi Y, Turka LA: Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 172;6065-6073, 2004
DOI
PUBMED
|
7 |
Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 21;685-711, 2003
DOI
ScienceOn
|
8 |
Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM, Kubes P: TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 173;7070-7077, 2004
DOI
PUBMED
|
9 |
Rahman AH, Cui W, Larosa DF, Taylor DK, Zhang J, Goldstein DR, Wherry EJ, Kaech SM, Turka LA: MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J Immunol 181;3804-3810, 2008
DOI
PUBMED
|
10 |
Marsland BJ, Kopf M: Toll-like receptors: paving the path to T cell-driven autoimmunity? Curr Opin Immunol 19;611-614, 2007
DOI
ScienceOn
|
11 |
Wong P, Pamer EG: CD8 T cell responses to infectious pathogens. Annu Rev Immunol 21;29-70, 2003
DOI
ScienceOn
|
12 |
Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J, Siadak AW, Brown TJ, Emswiler J, Raecho H, Larsen CP, Pearson TC, Ledbetter JA, Aruffo A, Mittler RS: 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 186;47-55, 1997
DOI
ScienceOn
|
13 |
Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 21;335-376, 2003
DOI
ScienceOn
|
14 |
Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY: TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 101;3029-3034, 2004
DOI
ScienceOn
|
15 |
Dougan M, Dranoff G: Immune therapy for cancer. Annu Rev Immunol 27;83-117, 2009
DOI
ScienceOn
|
16 |
Lee EK, Kang SM, Paik DJ, Kim JM, Youn J: Essential roles of toll-like receptor 4 signaling in arthritis induced by type II collagen antibody and LPS. Int Immunol 17;325-333, 2005
DOI
ScienceOn
|
17 |
Imanishi T, Hara H, Suzuki S, Suzuki N, Akira S, Saito T: Cutting edge: TLR2 directly triggers Th1 effector functions. J Immunol 178;6715-6719, 2007
DOI
PUBMED
|
18 |
Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1;135-145, 2001
DOI
PUBMED
ScienceOn
|
19 |
Quigley M, Martinez J, Huang X, Yang Y: A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood 113;2256-2264, 2009
DOI
ScienceOn
|